Single Cell Analysis Market Report Seventh Edition, 2026-2031

The seventh edition of DeciBio’s Single Cell Analysis Market Report provides a comprehensive assessment of the global single cell analysis market landscape, as well as a forward-looking perspective of the market through 2031. Content includes detailed market sizing and growth forecasts, key technology advancements across sequencing and multiomic platforms, adoption trends across academia and biopharma, competitive dynamics, and an evaluation of drivers, moderators, and emerging opportunities shaping the next phase of single cell analysis.
Publish Date
November 11, 2026
Category
Market Reports
Price
$ 8,000.00 USD
Publish Date
November 11, 2026
Category
Market Reports
Price
$ 8,000.00 USD
Publish Date
November 11, 2026
Category
Market Reports
Price
$ 8,000.00 USD

Report Summary

The single cell analysis (SCA) market, which is increasingly established, is comprised of sequencing (i.e., that assess nucleic acids such as DNA or RNA) and proteomic technologies that assess analytes at the level of single cells, rather than at the level of an entire cell population.

The seventh edition of this report takes a completely updated and comprehensive look at the SCA market. We assess the SCA market across 6 segments and 29 subsegments: customer (academia, biopharma, applied markets, clinical), workflow step (e.g., tissue dissociation, sample preparation, downstream analysis), analyte (e.g., RNA, DNA, epigenetic, protein, multiomic, other), field-of-study (e.g., oncology, basic cell biology, stem cell biology, microbiology, neurology, immunology, other), product type (e.g., instruments, reagents, services, other) and geography (e.g., U.S., Europe, China, Asia-Pacific, ROW). For each of these segments, we provide an estimated market size and growth from 2026 to 2031, as well as key growth drivers and moderators.

We review key factors driving future growth including 1) Expanding complexity of pharma’s pipelines that pull SCA into programs that previously relied on bulk approaches 2) Academic infrastructure that supports continued SCA innovation and data generation 3) Demand for biological foundation models that spurs large-scale projects 4) The maturity of SC allowing it to be moved further into translational and clinical stages. On the contrary, we comment on trends that moderate growth, such as 1) High project costs for large-scale implementation 2) Upstream processing as a growing bottleneck 3) Reproducibility and workflow standardization gaps, driving need for expertise before adoption 4) Vendor consolidation, which can create uncertainty around adoption decisions

In addition, we include output from a primary research campaign across 80 single cell researchers in academia, biopharma, and CRO settings. We capture current and anticipated spend, analyte trends (e.g., RNA, DNA, multiomics), platform acquisition trends (i.e., plans on buying additional instruments), and vendor feedback.

‍

Report Scope

Technologies and Revenues Included:

  • Single cell analysis – the study of single cell biology, primarily using sequencing-based analysis of analytes (e.g., RNA / DNA sequencing); analysis can also include other molecular signatures (e.g., protein, epigenetic, multiomic)
  • Tissue dissociation, sample preparation (including single cell isolation),and downstream analysis spend
  • Instrument & reagent revenues associated with the purchase of single cell analysis platforms or reagents / kits used to run the assays, and service revenues to SCA tools manufacturers
  • Sales of products to academic, biotech /pharmaceutical companies, and CRO customers

Technologies and Revenues Excluded:

  • Spatial analysis tools are not accounted for in this report (e.g., 10x estimated spatial revenue is subtracted to estimate single cell revenues only)
  • Specialized bioinformatics offerings that are not provided by the SCA platform / vendor
  • Flow cytometry analysis that does not involve single cell sequencing

‍

Table of Contents

  • Introduction & Methodology
  • Executive Summary
  • Competitive Market Analysis
  • Market Analysis
  • Emerging Single Cell Technologies
  • Primary Market Research
  • Primary Vendor Feedback (Global License Only)
  • Competitive Analysis
  • Appendix

‍

Survey

  • The focus of this survey was to characterize the current use (or lack thereof) of single cell analysis across academia, biopharma, and CROs. Respondents were asked about their current use of SCA, including any instrument-free vendors, as well as expectations for future use over the next 12 months
  • The survey was distributed randomly to current SCA users; respondents vary from new adopters to highly established genomics core laboratories.
Distribution of Survey Respondents by Geography, Institution Type, and Platform Utilization (N = 80)
  • Survey Participants were asked about:
    • Traditional single cell technologies (e.g.,single cell RNA-seq), including use of different vendors, the number of instruments in their lab, instrument utility, and reasons for using SCA
    • Multi-omic single cell analysis (e.g., RNA +protein, RNA + DNA, etc.)
    • Instrument-free platforms (e.g., Parse Biosciences’ Evercode, etc.), including reasons for adoption, expected adoption timeframe, and satisfaction with current instrument-free platforms
    • Functional single cell analysis utilization

Segmentations Covered in Market Analysis

Customer: Buyers of SCA instruments, reagents, and consumables from manufacturers

  • Academia
  • Biopharma
  • Applied Markets
  • Clinical

Workflow: Individual steps in the SCA process starting from sample and ending with data

  • Tissue Dissociation
  • Sample Preparation
  • Downstream Analysis

Analyte: Application / analyte that is detected

  • RNA
  • DNA
  • Epigenetic
  • Protein
  • Multiomic
  • Other

Field-of-Study: Research focus including broad non-disease specific biological area as well as specific disease areas

  • Oncology
  • Immunology
  • Microbiology
  • Basic cell biology
  • Stem cell biology
  • Neurology
  • Other

Product Type: Type of product that manufacturer sells to its customers

  • Instruments (including systems, service contract, and software)
  • Reagents (including reagents and consumables)
  • Services
  • Other

Geography: Country / region of the world

  • U.S.
  • Europe
  • China
  • Asia Pacific (APAC, ex-China)
  • Rest-of-the-world (ROW)

Companies Profiled in Competitive Analysis

  • 10x Genomics
  • Waters
  • Illumina (Fluent Biosciences)
  • MGI
  • Bruker
  • Qiagen (Parse Biosciences)
  • Takara Bio
  • Mission Bio
  • Singleron

‍

The single cell analysis (SCA) market, which is increasingly established, is comprised of sequencing (i.e., that assess nucleic acids such as DNA or RNA) and proteomic technologies that assess analytes at the level of single cells, rather than at the level of an entire cell population.

The seventh edition of this report takes an updated and comprehensive look at the SCA market. We assess the SCA market across 6 segments and 29 subsegments: customer (academia, biopharma, applied markets, clinical), workflow step (e.g., tissue dissociation, sample preparation, downstream analysis), analyte (e.g., RNA, DNA, epigenetic, protein, multiomic, other), field-of-study (e.g., oncology, basic cell biology, stem cell biology, microbiology, neurology, immunology, other), product type (e.g., instruments, reagents, services, other) and geography (e.g., U.S., Europe, China, Asia-Pacific, ROW). For each of these segments, we provide an estimated market size and growth from 2026 to 2031, as well as key growth drivers and moderators.

The Seventh Edition of this report is informed by 24 interviews as well as a survey of 80 stakeholders across academia, biopharma, and CROs.

‍

Segmentations Covered in Market Analysis

Customer: Buyers of SCA instruments, reagents, and consumables from manufacturers

  • Academia
  • Biopharma
  • Applied Markets
  • Clinical

Workflow: Individual steps in the SCA process starting from sample and ending with data

  • Tissue Dissociation
  • Sample Preparation
  • Downstream Analysis

Analyte: Application / analyte that is detected

  • RNA
  • DNA
  • Epigenetic
  • Protein
  • Multiomic
  • Other

Field-of-Study: Research focus including broad non-disease specific biological area as well as specific disease areas

  • Oncology
  • Immunology
  • Microbiology
  • Basic cell biology
  • Stem cell biology
  • Neurology
  • Other

Product Type: Type of product that manufacturer sells to its customers

  • Instruments (including systems, service contract, and software)
  • Reagents (including reagents and consumables)
  • Services
  • Other

Geography: Country / region of the world

  • U.S.
  • Europe
  • China
  • Asia Pacific (APAC, ex-China)
  • Rest-of-the-world (ROW)

‍

‍

Purchase Options

Summary Report
PDF deck with summarized feedback from stakeholders
Interview Transcripts
Individual PDFs of call transcripts with stakeholders
Report + Transcript Bundle
This package includes both the PDF deck and transcripts, providing a comprehensive understanding of stakeholders' views. You will receive a summarized report in the form of a PDF deck, as well as the full transcript of the discussions.
Report + ARIA Bundle
This package includes a summarized report in the form of a PDF deck, as well as access to Aria, an AI-powered tool that lets you chat directly with the board transcripts.
Browse Individual Transcripts
Individual call transcript of a single stakeholder discussing their views. This option is ideal for those who are interested in a specific stakeholder's perspective and insights on the topic.
Summary Report
PDF deck with summarized feedback from stakeholders
Interview Transcripts
Individual PDFs of call transcripts with stakeholders
Report + Transcript Bundle
This package includes both the PDF deck and transcripts, providing a comprehensive understanding of stakeholders' views. You will receive a summarized report in the form of a PDF deck, as well as the full transcript of the discussions.
Price
$ 8,000.00 USD
Single Cell Report
+
Spatial Report
Bundle the Single Cell Report with Spatial today and receive 20% off your order.
Bundle price applied automatically when you add both reports at the same license tier.
View Spatial Report
You save 20%
i
Bundle available with Individual, Site, and Global licenses. Both reports are licensed at the tier you select above.
ADD-ON
TRANSCRIPTS + DECICHAT ACCESS

Go deeper than the report. Get all 24 interviews across academia, biopharma, and CROs, plus querying access to DeciChat, DeciBio's AI tool for exploring the interview insights.

Available with any license.

Inquire about pricing →
Download Sample
To claim your free report, simply fill out the form below with your contact information, and we’ll send it to you right away. Don’t miss out on this opportunity to gain a competitive edge in your industry. Sign up now!
Request Access
Summary Report
PDF deck with summarized feedback from stakeholders
Interview Transcripts
Individual PDFs of call transcripts with stakeholders
Report + Transcript Bundle
This package includes both the PDF deck and transcripts, providing a comprehensive understanding of stakeholders' views. You will receive a summarized report in the form of a PDF deck, as well as the full transcript of the discussions.
Price
$ 8,000.00 USD
Price
$ 8,000.00 USD
Summary Report
PDF deck with summarized feedback from stakeholders
Interview Transcripts
Individual PDFs of call transcripts with stakeholders
Report + Transcript Bundle
This package includes both the PDF deck and transcripts, providing a comprehensive understanding of stakeholders' views. You will receive a summarized report in the form of a PDF deck, as well as the full transcript of the discussions.
Price
$ 8,000.00 USD

Experience the DeciBio Difference

Engage with our experts at DeciBio to discover how our tailored solutions can meet your unique needs.
Request Demo Today

Experience the DeciBio Difference

Engage with our experts at DeciBio to discover how our tailored solutions can meet your unique needs.
Request Demo Today
  • $ 8,000.00 USD
  • $ 11,500.00 USD
  • $ 13,500.00 USD

‍

  • Report license for one user
  • Report license can be shared by unlimited users within one corporate location
  • Includes an additional report section on vendor feedback from current single cell analysis users, raw data corresponding to the survey in the report (N=80) and can be shared globally by unlimited users across all company locations

‍

Buy now
Precision Medicine is evolving at a rapid pace

Discover how we can help

Get in Touch

Market Snapshot

Market Outlook · 2026-2031
$1.3B → $1.9B
Global market size
8%
CAGR
Primary Research
24expert interviews
80survey respondents
Report Coverage
6 segments · 29 sub-segments
9 company profiles
Free Sample
Preview the table of contents and selected slides before you buy.
Download Sample